The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detection of MET amplification (METamp) in patients with EGFR mutant (m) NSCLC after first-line (1L) osimertinib.
 
Helena Alexandra Yu
Consulting or Advisory Role - AstraZeneca; Black Diamond Therapeutics; Blueprint Medicines; C4 Therapeutics; Cullinan Oncology; Daiichi Sankyo; Janssen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Blueprint Medicines; Cullinan Oncology (Inst); Daiichi Sankyo (Inst); Erasca, Inc (Inst); Janssen Oncology (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Lilly
Other Relationship - Astellas Pharma
 
Keith Kerr
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Medscape; Merck KGaA; MSD; Novartis; Pfizer; prIME Oncology; Roche; Ventana Medical Systems
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck KGaA; MSD; Novartis; Pfizer; Regeneron; Roche; Takeda; Ventana Medical Systems
 
Christian Diego Rolfo
Leadership - ELSEVIER; ESMO; European School Oncology; IASLC; International Society of Liquid Biopsy
Consulting or Advisory Role - Amgen; Archer; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Pharmaceuticals; BostonGene; Bristol-Myers Squibb; Clinical Education Alliance; Cor2Ed; Daiichi Sankyo Europe GmbH; Diverse Health Hub; Eisai; EMD Serono; EMD Serono; General Dynamics Information Technology (GDIT); Genzyme; Guardant Health; Inivata; Intellisphere; Janssen Scientific Affairs; LUNGEVITY; MedStar Health; Merck Serono; Mirati Therapeutics; MJH Live Events; Novartis; ONCLIVE; Physicans' Education Resource; Physicans' Education Resource; Regeneron; ROCHE
Speakers' Bureau - AstraZeneca; Guardant Health; MSD; Roche Molecular Diagnostics
Research Funding - Lung Cancer Research Foundation
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Guardant Health
 
Jian Fang
No Relationships to Disclose
 
Giovanna Finocchiaro
Consulting or Advisory Role - Amgen; MSD
Speakers' Bureau - AstraZeneca; Roche
 
Kam-Hung Wong
No Relationships to Disclose
 
Remi Veillon
Consulting or Advisory Role - Janssen Oncology
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Roche; Sanofi/Aventis; Takeda
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Pfizer
 
Terufumi Kato
Employment - Lilly (I)
Honoraria - Amgen; AstraZeneca; BeiGene; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Janssen; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Takeda
Consulting or Advisory Role - AstraZeneca; BeiGene; DaiichiSankyo; Janssen; Merck Serono; MSD; Novartis; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BeiGene (Inst); Blueprint Medicines (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Haihe Biopharma (Inst); Lilly (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Takeda (Inst); Turning Point Therapeutics (Inst)
 
James Chih-Hsin Yang
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Amgen (Inst); AstraZeneca; AstraZeneca (Inst); Bayer; Blueprint Medicines; Boehringer Ingelheim; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; Daiichi Sankyo (Inst); G1 Therapeutics; GlaxoSmithKline (Inst); Hansoh; Incyte; Janssen (Inst); Lilly; Merck Serono; Merck Serono (Inst); MSD Oncology; MSD Oncology (Inst); Novartis; Novartis (Inst); Ono Pharmaceutical; Pfizer; Takeda; Takeda (Inst); Yuhan
Travel, Accommodations, Expenses - Pfizer
 
Ernest Nadal
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Lilly; Merck Serono; MSD; Pfizer; Roche; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Merck Serono (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Jo Raskin
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly O.; Merck KGaA; Pfizer
 
Xiuning Le
Consulting or Advisory Role - Abbvie; ArriVent Biopharma; AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Lilly; EMD Serono; Hengrui Therapeutics; Janssen Oncology; Lilly; Novartis; Sensei Biotherapeutics; Spectrum Pharmaceuticals
Research Funding - ArriVent Biopharma (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Regeneron (Inst); Teligene (Inst)
Travel, Accommodations, Expenses - EMD Serono; Spectrum Pharmaceuticals
 
Niki Karachaliou
Employment - Merck KGaA
 
Barbara Ellers-Lenz
Employment - Merck KGaA
 
Aurora OBrate
Employment - Merck KGaA
 
Christopher Stroh
Employment - Merck KGaA
 
Nadine Piske
Employment - Merck KGaA
 
Carsten Boesler
Employment - Merck KGaA
 
Jinji Yang
No Relationships to Disclose
 
Julien Mazieres
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Merck KGaA; MSD; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Roche/Genentech (Inst)